After the books closed: the quarter's biggest news happened too late to be in the numbers
The model's full reasoning — Q2 2023 call → NOThe question asks whether management reports that the most important positive developments of the period happened so late in the reported period or shortly after it ended that the results contain little or none of their effect, with management itself marking the timing. Let me analyze the transcript carefully. Key developments mentioned: 1. Fusion 2.0 field upgrade - initiated in Q2, started with first customers in June, expected significant percentage upgraded by year-end 2. PhenoImager HT improvements - introduced in July (after quarter-end) 3. Signature panels for HT - rolling launch throughout 2023 4. Discovery panels - rolling launch throughout 2023 Let me look for specific timing language: On Fusion 2.0: "The Fusion 2.0 instrument hardware and software field upgrade was initiated as of the second quarter. This upgrade includes a multi-slide carrier... Field upgrades started with our first customers in June and we expect a significant percentage of our PhenoCycler-Fusion customers to upgrade by year-end." On HT improvements: "In July, we introduced improvements to the HT that moves post-processing and tissue analysis workflow directly on to the HT for on instrument and real-time compute." On the panels: "These biomarker panels are part of the PhenoCode reagent brand and included our Discovery panels for the PhenoCycler-Fusion and the signature panels for the PhenoImager HT. The Discovery panels have a rolling launch throughout 2023" Now, does management say these late developments mean the results contain little or none of their effect? Looking at the discussion of pull-through: "In the first half of 2023, we are seeing encouraging results of our emphasis on driving reagent growth. The annualized second quarter reagent pull-through has now increased to the mid-$30,000 range for both the PhenoCycler and HT" Management discusses the Fusion 2.0 upgrade as something that will drive future pull-through, and the HT improvements as introduced in July (after quarter-end). But does management explicitly say the reported results contain little or none of these effects? Looking at the response to Mark Massaro's question about reagent revenue growth lagging: "I suspect you'll see those trends start to change a little bit.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| SWBI | Smith & Wesson Brands, Inc. | Q1 2023 | 2022-09-08 | C+ |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
OPK · Q1 2022 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...YES The transcript shows management treating the ModeX acquisition (announced and closed on the call date, May 9) and the Sema4/GeneDx deal (closed April 29) as major positive developments that occurred after the Q1 period ended. These are framed as key steps toward unlocking value and are highlighted as the "exciting announcement" that changed the call format.
RNW · Q2 2022 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...YES The transcript shows management explicitly marking the timing of key positive developments: 400 MW commissioned "since the end of the quarter" (bringing operating capacity to 7 GW today, with another 400 MW scheduled "over the next couple of weeks"), plus the completed Telangana acquisition adding 260 MW.
ASM · Q4 2023 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...